Top compounds associated with response to SMYD1


Feature Type Standardized
Nominal ANOVA
mRNA paclitaxel gCSI pan-cancer AAC -0.022 0.7
mRNA paclitaxel CTRPv2 pan-cancer AAC 0.012 0.7
mRNA SKI-II CTRPv2 pan-cancer AAC -0.014 0.7
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.021 0.7
mRNA MK-2206 GDSC1000 pan-cancer AAC 0.013 0.7
mRNA MS-275 CTRPv2 pan-cancer AAC -0.012 0.7
mRNA JQ12 GDSC1000 pan-cancer AAC 0.013 0.7
mRNA decitabine CTRPv2 pan-cancer AAC -0.01 0.7
mRNA BRD-K13999467 CTRPv2 pan-cancer AAC 0.013 0.7
mRNA erastin CTRPv2 pan-cancer AAC 0.013 0.7
Download CSV